since 2000, they have spent $45,000,000 of investment money without making a dime. They keep issuing shares to keep the cash cow coming in...they might make money in 2017... This has been going on with these stem companies for years... YOU pay their salaries
In 2008 this went from .64 cents to .07 cents. They are finally entering the point of which they can do some clinical trials. They have accomplished a lot, but as all these stem cell companies, it is at a Turtles pace.
That is a heck of a lot of money and I only have been following bcli for about two years. CUR spends about $3 million per quarter (gosh hope I am recalling this correctly) and this company is basically their competition, but CUR is working on a lot more.
With a market cap around $30 million; it is difficult to project appropriate value due to lack of ALS evidence with exception to the Miracle at Mayo. If in Phase I this is reaffirmed and these stem cells can be considered for other Dystrophy diseases and Parkinson's then the sky is the limit.
There will definitely be a case of coverage once one of these regenerative stem cell companies are approved, but we'll cross that bridge at a later date.